Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harmony Biosciences Holdings (HRMY) Change in Account Payables (2019 - 2025)

Historic Change in Account Payables for Harmony Biosciences Holdings (HRMY) over the last 7 years, with Q3 2025 value amounting to -$2.0 million.

  • Harmony Biosciences Holdings' Change in Account Payables rose 8386.96% to -$2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.8 million, marking a year-over-year increase of 75870.83%. This contributed to the annual value of -$5.4 million for FY2024, which is 16016.31% down from last year.
  • Latest data reveals that Harmony Biosciences Holdings reported Change in Account Payables of -$2.0 million as of Q3 2025, which was up 8386.96% from $10.8 million recorded in Q2 2025.
  • In the past 5 years, Harmony Biosciences Holdings' Change in Account Payables ranged from a high of $10.8 million in Q2 2025 and a low of -$12.2 million during Q3 2024
  • In the last 5 years, Harmony Biosciences Holdings' Change in Account Payables had a median value of $1.8 million in 2021 and averaged $915368.4.
  • Within the past 5 years, the most significant YoY rise in Harmony Biosciences Holdings' Change in Account Payables was 402147.65% (2024), while the steepest drop was 5052916.67% (2024).
  • Over the past 5 years, Harmony Biosciences Holdings' Change in Account Payables (Quarter) stood at -$3.2 million in 2021, then crashed by 97.07% to -$6.3 million in 2022, then surged by 198.93% to $6.2 million in 2023, then plummeted by 48.16% to $3.2 million in 2024, then tumbled by 161.02% to -$2.0 million in 2025.
  • Its last three reported values are -$2.0 million in Q3 2025, $10.8 million for Q2 2025, and $3.7 million during Q1 2025.